Select Medical (SEM) Projected to Release Earnings on Thursday

Select Medical (NYSE:SEM) is expected to post its Q2 2026 results after the market closes on Thursday, July 30th. Analysts expect the company to announce earnings of $0.29 per share and revenue of $1.3973 billion for the quarter. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Parties are encouraged to explore the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Friday, August 7, 2026 at 9:00 AM ET.

Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the prior year, the company earned $0.44 EPS. Select Medical’s quarterly revenue was up 5.0% on a year-over-year basis. On average, analysts expect Select Medical to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Select Medical Stock Performance

SEM opened at $16.51 on Wednesday. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.88. Select Medical has a 12-month low of $11.65 and a 12-month high of $16.99. The business has a 50 day moving average of $16.54 and a 200-day moving average of $16.16. The stock has a market cap of $2.05 billion, a price-to-earnings ratio of 15.58, a PEG ratio of 0.95 and a beta of 1.01.

Analysts Set New Price Targets

Several equities research analysts have issued reports on SEM shares. Weiss Ratings raised Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, June 4th. Zacks Research upgraded shares of Select Medical from a “strong sell” rating to a “hold” rating in a report on Monday, May 4th. Finally, Mizuho reissued a “neutral” rating and issued a $16.50 price objective (down from $17.00) on shares of Select Medical in a research report on Tuesday, May 12th. One equities research analyst has rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $15.50.

Institutional Trading of Select Medical

Hedge funds and other institutional investors have recently bought and sold shares of the business. Quarry LP acquired a new position in shares of Select Medical during the 4th quarter worth approximately $26,000. Quantbot Technologies LP acquired a new stake in shares of Select Medical in the third quarter valued at approximately $27,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Select Medical in the fourth quarter valued at approximately $28,000. Smartleaf Asset Management LLC boosted its stake in shares of Select Medical by 37.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock valued at $43,000 after buying an additional 788 shares during the period. Finally, Wilmington Savings Fund Society FSB grew its position in Select Medical by 20.9% during the third quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock worth $74,000 after buying an additional 999 shares in the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.